Marshall Wace, LLP Lensar, Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Lensar, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 13,176 shares of LNSR stock, worth $179,193. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,176Holding current value
$179,193% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LNSR
# of Institutions
72Shares Held
5.05MCall Options Held
58.3KPut Options Held
19K-
North Run Capital, LP Wellesley, MA1.1MShares$14.9 Million7.54% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA545KShares$7.41 Million0.08% of portfolio
-
Dimensional Fund Advisors LP Austin, TX478KShares$6.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA442KShares$6.02 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny314KShares$4.27 Million0.01% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $150M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...